Correlation Between PepsiCo and In Veritas
Can any of the company-specific risk be diversified away by investing in both PepsiCo and In Veritas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PepsiCo and In Veritas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PepsiCo and In Veritas Medical, you can compare the effects of market volatilities on PepsiCo and In Veritas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PepsiCo with a short position of In Veritas. Check out your portfolio center. Please also check ongoing floating volatility patterns of PepsiCo and In Veritas.
Diversification Opportunities for PepsiCo and In Veritas
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between PepsiCo and IVME is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PepsiCo and In Veritas Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In Veritas Medical and PepsiCo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PepsiCo are associated (or correlated) with In Veritas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In Veritas Medical has no effect on the direction of PepsiCo i.e., PepsiCo and In Veritas go up and down completely randomly.
Pair Corralation between PepsiCo and In Veritas
If you would invest 0.01 in In Veritas Medical on September 13, 2024 and sell it today you would earn a total of 0.00 from holding In Veritas Medical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
PepsiCo vs. In Veritas Medical
Performance |
Timeline |
PepsiCo |
In Veritas Medical |
PepsiCo and In Veritas Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PepsiCo and In Veritas
The main advantage of trading using opposite PepsiCo and In Veritas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PepsiCo position performs unexpectedly, In Veritas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In Veritas will offset losses from the drop in In Veritas' long position.PepsiCo vs. Coca Cola Femsa SAB | PepsiCo vs. Keurig Dr Pepper | PepsiCo vs. Embotelladora Andina SA | PepsiCo vs. Coca Cola European Partners |
In Veritas vs. Commonwealth Bank of | In Veritas vs. Avadel Pharmaceuticals PLC | In Veritas vs. Catalent | In Veritas vs. Alvotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |